サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654666

世界の角膜移植市場-2025年～2033年

Global Corneal Transplant Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
世界の角膜移植市場-2025年～2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の角膜移植市場は、2024年に5億2,388万米ドルに達し、2033年には1兆69億5,000万米ドルに達し、予測期間2025-2033年にCAGR 7.59％で成長すると予測されています。

角膜移植は、角膜形成術としても知られ、視力を回復し、目の健康を改善するために、損傷または病気の角膜をドナーの角膜と交換する外科的処置です。角膜は目の前面にあるドーム状の透明な層で、その健康状態は適切な視力を得るために極めて重要です。角膜移植は一般的に、円錐角膜、角膜ジストロフィー、角膜瘢痕、感染症などの疾患が著しい視力障害や失明につながる場合に行われます。この手術は、角膜の損傷の程度に応じて、全層移植（貫通角膜移植術）または部分的移植（ラメラ角膜移植術）を行うことができます。

レーザー支援手術や低侵襲手術などの手術技術の進歩により、角膜移植の治療成績は大幅に改善され、回復時間の短縮や移植片の生存率の向上につながっています。

市場力学：

促進要因と抑制要因

角膜疾患と眼疾患の増加

角膜疾患や眼障害の増加は、角膜移植の需要を促進する主な要因です。円錐角膜、角膜ジストロフィー、感染症、瘢痕化などの症状が一般的になりつつあり、視力を回復する方法として移植の必要性が高まっています。例えば、2022年の国立衛生研究所によると、円錐角膜は一部の地域、中東で人口の約5％が罹患しています。

これらの疾患は深刻な視力障害や失明を引き起こす可能性があり、多くの患者が解決策として角膜移植を求めるようになります。これらの疾患の増加は特に若年層で顕著であり、円錐角膜のような疾患は10代や20代の多くの人々に影響を及ぼしています。

角膜移植は、いくつかの要因から世界中で増加しています。この成長に伴い、研究機関やクリニックは需要の高まりに対応するため、これらの手術を行っています。例えば、LVPEI（L V Prasad Eye Institute）は過去35年間で、12万個以上の角膜の採取に成功しており、アジア太平洋地域で最大の角膜提供プログラムとなっています。現在では、年間1万2,000個以上の角膜を採取することができ、移植用のドナー角膜の確保に大きく貢献しています。このような処置の増加は、実施に必要な機器やキットの需要を増加させ、市場の成長にさらに貢献すると予想されます。

角膜移植に関連する合併症

角膜移植に伴う合併症やリスクは、患者とヘルスケア専門家の双方を落胆させ、市場の成長を阻害する可能性があります。角膜移植は一般的に成功しているが、移植片の拒絶反応、感染症、角膜の腫れなど、移植を失敗させる可能性のある潜在的な問題は依然として存在します。これらの問題は、拒絶反応を防ぐために追加の手術や長期の薬物療法を必要とする可能性があり、回復過程を複雑にするため、移植の普及を遅らせ、市場の拡大に影響を与える可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 角膜疾患および眼疾患の増加
    • 抑制要因
      • 角膜移植に伴う合併症
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • SWOT分析
  • アンメットニーズ

第6章 手順の種類別

  • 内皮角膜移植
  • 全層角膜移植
  • 前層角膜移植術（ALK）
  • 角膜輪部幹細胞移植
  • 人工的な角膜移植
  • その他

第7章 デバイスタイプ別

  • 顕微手術器具
  • マイクロケラトーム
  • 光干渉断層撮影（OCT）
  • 人工角膜
  • その他

第8章 タイプ別

  • 人間の角膜
  • 合成

第9章 手術の種類別

  • 従来の手術
  • レーザー手術

第10章 適応症別

  • フックス内皮ジストロフィー
  • 感染性角膜炎
  • 水疱性角膜症
  • 円錐角膜
  • 再移植手術
  • 角膜瘢痕
  • 角膜潰瘍
  • その他

第11章 最終用途別

  • 病院
  • 眼科クリニック
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第14章 企業プロファイル

  • Carl Zeiss AG
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 過去および予測の製品販売
      • 製品販売量
    • 財務概要
      • 会社の収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • CorneaGen
  • Ziemer Ophthalmic Systems AG
  • RUMEX International Co.
  • CorNeat Vision
  • KeraMed, Inc.
  • Corza Ophthalmology
  • Inami & CO.,Ltd
  • Leica Microsystems
  • Surtex Instruments Limited.
  • Similar data will be provided for each market player.
  • プロセサファーマシューティカルズ株式会社
    • パイプライン製品の説明
    • 製品の主要業績評価指標（KPI）
    • 主な活動
    • 市場参入のタイムライン
    • 製品普及率
    • 売上予測と予測
  • バンダ製薬株式会社
  • レネクシオンアイルランドリミテッド
  • アクリプス・セラピューティクス
  • 各市場参入企業に対しても同様のデータが提供されます。

第15章 付録

目次
Product Code: PH9100

The global corneal transplant market reached US$ 523.88 million in 2024 and is expected to reach US$ 1,006.95 billion by 2033, growing at a CAGR of 7.59% during the forecast period 2025-2033.

Corneal transplant, also known as keratoplasty, is a surgical procedure in which a damaged or diseased cornea is replaced with a donor cornea to restore vision and improve eye health. The cornea is the transparent, dome-shaped layer at the front of the eye, and its health is crucial for proper vision. Corneal transplants are typically performed when conditions such as keratoconus, corneal dystrophies, corneal scarring, and infection lead to significant vision impairment or blindness. The procedure can involve either full-thickness transplants (penetrating keratoplasty) or partial-thickness transplants (lamellar keratoplasty), depending on the extent of the corneal damage.

Advancements in surgical techniques, such as laser-assisted and minimally invasive procedures, have significantly improved the outcomes of corneal transplants, reducing recovery times and increasing graft survival rates.

Market Dynamics: Drivers & Restraints

Growing number of corneal diseases and eye disorders

The growing number of corneal diseases and eye disorders is a major factor driving the demand for Corneal Transplants. Conditions like keratoconus, corneal dystrophies, infections, and scarring are becoming more common, which is increasing the need for transplants as a way to restore vision. For instance, according to the National Institute of Health in 2022, keratoconus affects about 5% of the population in few regions, Middle East.

These conditions can cause serious vision problems and even blindness, pushing many patients to seek corneal transplants as a solution. The rise in these disorders is particularly noticeable among younger people, with conditions like keratoconus affecting many in their teens or twenties.

There is a growing incidnce of corneal transplantations across the globe due to several factors. With this growth, the institutes and clinics are performing these procedures to meet the rising demand. For instance, Over the past 35 years, LVPEI (L V Prasad Eye Institute) has successfully harvested more than 120,000 corneas, making it the largest corneal donation program in the Asia-Pacific region. Currently, the institute is able to harvest over 12,000 corneas annually, contributing significantly to the availability of donor corneas for transplantation. This increasing procedures is expected to increase the demand for the devices and kits required for performing, further contributing to the growing market.

Complications associated with corneal transplantation

Complications and risks associated with Corneal Transplants could hold back the market's growth by discouraging both patients and healthcare professionals. Although corneal transplants are generally successful, there are still potential issues like graft rejection, infections, and corneal swelling that could cause the transplant to fail. These problems might require extra surgeries or long-term medication to prevent rejection, complicating the recovery process, which may lead to slower adoption of transplants and impact the market's expansion.

Segment Analysis

The global corneal transplant market is segmented based on procedure type, device type, surgery type, indication, end-user, and region.

Treatment:

Microsurgical instruments segment is expected to dominate the global corneal transplant market share

The microsurgical instruments segment is expected to hold a dominant position in the corneal transplant market due to the significant role these specialized tools play in the success of corneal transplant surgeries. Corneal transplant procedures are highly delicate and require precise, minimally invasive techniques to ensure proper graft placement and reduce the risk of complications. Microsurgical instruments, such as fine forceps, micro scissors, and laser-assisted tools, allow surgeons to perform these intricate surgeries with exceptional precision and control.

As advancements in surgical techniques continue, microsurgical instruments are becoming more sophisticated, improving outcomes, and reducing recovery times for patients. This advanced features are creating a high demand for these devices. Several market players are increasing developing advanced m,icrosurgical instruments to perform penetrating keratoplasty (full-thickness transplants) and lamellar keratoplasty (partial-thickness transplants), which require extremely fine and accurate cuts to minimize tissue damage and enhance graft survival.

With the increasing number of corneal transplants being performed globally, the demand for advanced microsurgical instruments is growing, as they are integral to ensuring the safety and success of these procedures.

Geographical Analysis

North America is expected to hold a significant position in the global corneal transplant market share

North America is expected to maintain a leading position in the global corneal transplant market for several key reasons. The region's advanced healthcare infrastructure, high awareness of eye health, and access to cutting-edge medical technologies all play a major role. Both the United States and Canada have well-established healthcare systems with top-tier medical facilities and highly skilled ophthalmologists, making them leaders in performing complex corneal transplants. This expertise ensures high success rates, making North America a go-to destination for corneal transplants.

The growing prevalence of corneal diseases like keratoconus and corneal dystrophies, along with an aging population more prone to eye conditions, is also driving demand for corneal transplants in the region. For instance, according to the publication by the National Institute of Health in 2024, in the United States, the estimated prevalence of Fuchs' Endothelial Corneal Dystrophy (FECD) among individuals over the age of 65 is 1.12%. The condition is notably more common in women and the White population compared to other ethnic groups.

Moreover, continuous advancements in surgical techniques as well as innovations in artificial corneas and stem cell therapies, are strengthening North America's position in the market. For instance, in June 2024, CorneaGen launched Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes.

The region's ongoing investment in research and development in ophthalmology continues to improve transplant outcomes, reducing recovery times and increasing success rates. These factors all contribute to North America's dominant role in the global corneal transplant market.

Competitive Landscape

The major global players in the corneal transplant market include Carl Zeiss AG, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., CorNeat Vision, KeraMed, Inc., Corza Ophthalmology, Inami & CO., Ltd, Leica Microsystems and Surtex Instruments Limited. among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Corneal Transplant Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Procedure Type
  • 3.2. Snippet by Device Type
  • 3.3. Snippet by Type
  • 3.4. Snippet by Surgery Type
  • 3.5. Snippet by Indication
  • 3.6. Snippet by End-User
  • 3.7. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing number of corneal diseases and eye disorders
    • 4.1.2. Restraints
      • 4.1.2.1. Complications associated with the corneal transplantation
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Procedure Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 6.1.2. Market Attractiveness Index, By Procedure Type
  • 6.2. Endothelial Keratoplasty*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Penetrating Keratoplasty
  • 6.4. Anterior Lamellar Keratoplasty (ALK)
  • 6.5. Corneal Limbal Stem Cell Transplant
  • 6.6. Artificial Corneal Transplant
  • 6.7. Others

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Microsurgical Instruments*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Microkeratome
  • 7.4. Optical Coherence Tomography (OCT)
  • 7.5. Artificial Corneas
  • 7.6. Others

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Human Cornea*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Synthetic

9. By Surgery Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
    • 9.1.2. Market Attractiveness Index, By Surgery Type
  • 9.2. Conventional Surgery*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Laser-Assisted Surgery

10. By Indication

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.1.2. Market Attractiveness Index, By Indication
  • 10.2. Fuch's Endothelial Dystrophy*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Infectious Keratitis
  • 10.4. Bullous Keratopathy
  • 10.5. Keratoconus
  • 10.6. Regraft Procedures
  • 10.7. Corneal Scarring
  • 10.8. Corneal Ulcers
  • 10.9. Others

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Ophthalmic Clinics
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.9.1. U.S.
      • 12.2.9.2. Canada
      • 12.2.9.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.9.1. Germany
      • 12.3.9.2. U.K.
      • 12.3.9.3. France
      • 12.3.9.4. Spain
      • 12.3.9.5. Italy
      • 12.3.9.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.9.1. Brazil
      • 12.4.9.2. Argentina
      • 12.4.9.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.9.1. China
      • 12.5.9.2. India
      • 12.5.9.3. Japan
      • 12.5.9.4. South Korea
      • 12.5.9.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

Key Market Players

  • 14.1. Carl Zeiss AG*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio
      • 14.1.2.1. Product Description
      • 14.1.2.2. Product Key Performance Indicators (KPIs)
      • 14.1.2.3. Historic and Forecasted Product Sales
      • 14.1.2.4. Product Sales Volume
    • 14.1.3. Financial Overview
      • 14.1.3.1. Company Revenue's
      • 14.1.3.2. Geographical Revenue Shares
      • 14.1.3.3. Revenue Forecasts
    • 14.1.4. Key Developments
      • 14.1.4.1. Mergers & Acquisitions
      • 14.1.4.2. Key Product Development Activities
      • 14.1.4.3. Regulatory Approvals etc.
    • 14.1.5. SWOT Analysis
  • 14.2. CorneaGen
  • 14.3. Ziemer Ophthalmic Systems AG
  • 14.4. RUMEX International Co.
  • 14.5. CorNeat Vision
  • 14.6. KeraMed, Inc.
  • 14.7. Corza Ophthalmology
  • 14.8. Inami & CO.,Ltd
  • 14.9. Leica Microsystems
  • 14.10. Surtex Instruments Limited.
  • Similar data will be provided for each market player.

Emerging Market Players

  • 14.11. Processa Pharmaceuticals, Inc.*
    • 14.11.1. Pipeline Products Description
    • 14.11.2. Product Key Performance Indicators (KPIs)
    • 14.11.3. Key Activities
    • 14.11.4. Market Entry Timelines
    • 14.11.5. Product Penetration Rate
    • 14.11.6. Sales Estimation and Projections
  • 14.12. Vanda Pharmaceuticals Inc.
  • 14.13. Renexxion Ireland Limited
  • 14.14. Aclipse Therapeutics
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us